Fig. 2

Survival analysis chart of baseline non-HCC patients during follow-up. A Cumulative normalization rate of AFP during follow-up in non-HCC patients with elevated baseline AFP; B Cumulative incidence of HCC during follow-up in non-HCC patients with elevated baseline AFP; C Cumulative abnormal rate of AFP during follow-up in non-HCC patients with normal baseline AFP; D Cumulative incidence of HCC during follow-up in non-HCC patients with normal baseline AFP. * P < 0.05